Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

FCA to reform investment management rules to improve competition

(Sharecast News) - The Financial Conduct Authority announced on Monday that it is looking at ways to make the investment management sector more innovative and competitive. The financial regulator said it is proposing reforms to its regime for alternative asset management to make it easier for new firms to enter the market and compete.

A more "streamlined and proportionate" regime will make it easier for firms to operate globally and encourage effective risk management, while ensuring that consumers remain protected, the FCA said.

UK asset managers, which manage a combined £12.3trn in mainstream assets and £2trn in alternative assets, are mostly governed by regulation that is derived from EU legislation, including the so-called alternative investment fund managers directive (AIFMD).

The government is now consulting on provisions that repeal AIFMD's firm-facing legislative requirements, the FCA said, and wants to create bespoke regimes for investment trusts and VC firms due to the different ways each sector operates.

"We want rules better tailored to UK investment managers. These could allow them to operate more efficiently, further supporting competition, competitiveness and economic growth," said Simon Walls, interim executive director of markets at the FCA.

"It's part of our wider work to streamline the regulatory regime for asset managers, to support the continued competitiveness of our world-leading financial services as outlined in our new strategy."

The FCA is now inviting comments on the proposals, ending on 9 June, and will consult on detailed rules in the first half of 2026.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.